Black Belt Therapeutics Ltd has a total of 26 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are AARON DIAMOND AIDS RES CENTER, FOOTE JEFFERSON and SHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Republic of Korea | 5 | |
#5 | United States | 3 | |
#6 | Singapore | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Goubier Anne | 26 |
#2 | Prinz Bianka | 26 |
#3 | Moulder Kevin | 26 |
#4 | Filosto Simone | 26 |
#5 | Eissler Nina | 26 |
#6 | Baruah Hemanta | 26 |
#7 | Salimu Josephine | 26 |
#8 | Merchiers Pascal | 26 |
#9 | Goyenechea Corzo Beatriz | 22 |
#10 | Goyenechea Beatriz | 2 |
Publication | Filing date | Title |
---|---|---|
CA3073085A1 | Cd38 modulating antibody | |
CA3072296A1 | Cd38 antibody | |
CA3066555A1 | Cd38 modulating antibody | |
AU2018280868A1 | CD38 modulating antibody | |
KR20200019669A | CD38 Modified Antibodies |